Single Entry
psoriasis:Ovarian Cancer Risk Scientists From Uni by psoriasis4
�A new genetic marker associated with ovarian cancer risk was recently discovered by an international research group,psoriasis, led by scientists from the Cancer Research Genetic Epidemiology Unit in the United Kingdom. Drs. Marc Goodman, Galina Lurie, Michael Carney, and Keith Terada of the University of Hawai’i the at M get fed up with noa’s Cancer Research Center of Hawai’i the participated in validation of the discovered genetic marker as a part of the Ovarian Cancer Association Consortium, a worldwide forum of scientists performing ovarian cancer research.
“The discovery . . . represents not only a triumph of team science, but also a fulfillment of the vision of the Ovarian Cancer Research Fund and its donors,” says Dr. Andrew Berchuck at Duke University, chair of the consortium.
Over the last six years, the consortium has been supported by generous donations from the family and friends of Kathryn Sladek Smith in the New York area. The results of this work appeared in the July 2, 2009 issue of Nature Genetics.
Ovarian cancer is the eighth most common cancer and the fifth leading cause of cancer death among women in the United States. The five-year relative survival rates are currently 93 percent for localized disease, 71 percent for regional disease, and 31 percent for distant disease. However, only 25 percent of women with ovarian carcinoma are diagnosed at a localized stage mostly because symptoms are vague and a reliable screening method for early detection has not been established.
Ovarian cancer is already known to be linked to the variations in the breast cancer genes, BRCA1 and BRCA2. But these variations are rare, and alone they account for less than five percent of all cases of ovarian cancer. It is likely that the remaining risk is due to a combination of several unidentified genes that individually carry a low to moderate risk of the disease.
The study used a genome-wide association design in which the frequencies of hundreds of thousands of genetic variations across the genome are compared between large numbers of cases and unaffected controls. Overall more than 20,000 women participated in this study.
In the first stage, more than 620,000 genetic variations were analyzed in the whole genome of 1,817 women with ovarian cancer and compared to 2,353 women without the disease. Through the Ovarian Cancer Association Consortium, the most promising markers were subsequently investigated among an additional 7,922 women with ovarian cancer and 10,577 women without disease.
The new marker was found on chromosome 9, close to the BNC2 (basonuclin 2) gene that encodes a protein which plays a role in regulation of DNA transcription and is highly expressed in reproductive tissues. This marker is present among 32% of women and contributes an estimated 0.7% to ovarian cancer risk.The association of this marker with risk was stronger for serous carcinoma, the most common (and most lethal) ovarian cancer subtype.
The Hawaii Ovarian Cancer Study is funded by the National Cancer Institute and includes 896 women diagnosed with ovarian cancer and more than a thousand women without the disease. The investigative team at the Cancer Research Center of Hawai’i is grateful to all of the study participants that contributed to this important discovery which paves the road to the early diagnosis of ovarian cancer, a deadly disease. In the future, the Consortium hopes that several more genetic markers will be identified, facilitating the establishment of a genetic screening test for ovarian cancer.
Source:
Sharon Shigemasa
University of Hawaii at Manoa
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Ovarian Cancer
>
Categories A-B
Abortion
Acid Reflux / GERD
ADHD
Aid / Disasters
Alcohol / Addiction / Illegal Drugs
Allergy
Alternative Medicine
Alzheimer’s / Dementia
Anxiety / Stress
Arthritis / Rheumatology
Asbestos / Mesothelioma
Asthma Autism
Back Pain
Bio-terrorism / Terrorism
Biology / Biochemistry
Bipolar
Bird Flu / Avian Flu
Blood / Hematology
Body Aches
Bones / Orthopaedics
Breast Cancer
>
Categories C-D
Cancer / Oncology
Cardiovascular / Cardiology
Caregivers / Homecare
Cervical Cancer / HPV Vaccine
Cholesterol
CJD / vCJD / Mad Cow Disease
Cleft Palate
Clinical Trials / Drug Trials
Colorectal Cancer
Complementary Medicine
Compliance
Conferences
COPD
Cosmetic Medicine
Crohn’s
Cystic Fibrosis
Dentistry
Depression
Dermatology
Diabetes Dyslexia
>
Categories E-G
Ear, Nose and Throat
Eating Disorders
Eczema / Psoriasis
Endocrinology
Epilepsy
Erectile Dysfunction
Eye Health / Blindness
Fertility
Fibromyalgia
Flu / Cold / SARS
GastroIntestinal / Gastroenterology
Genetics Gout
Gynecology
>
Categories H-L
Headache / Migraine
Health Insurance / Medical Insurance
Hearing / Deafness
Heart Disease
HIV / AIDS
Huntingtons Disease
Hypertension
Immune System / Vaccines
Infectious Diseases
Irritable-Bowel Syndrome
IT / Internet / E-mail
Litigation
Liver Disease / Hepatitis
Lung Cancer
Lupus
Lymphology / Lymphedema
Lymphoma / Leukemia
>
Categories M-O
Medical Devices / Diagnostics
Medical Malpractice
Medical Practice Management
Medical Students / Training
Medicare / Medicaid / SCHIP
Melanoma / Skin Cancer
Men’s Health
Menopause
Mental Health
MRI / PET / Ultrasound
MRSA / Drug Resistance
Multiple Sclerosis
Muscular Dystrophy / ALS
Myeloma
Neurology / Neuroscience
Nursing / Midwifery
Nutrition / Diet
Obesity / Weight Loss / Fitness
Ovarian Cancer
>
Categories P-R
Pain / Anesthetics
Palliative Care / Hospice Care
Pancreatic Cancer
Parkinson’s Disease
Pediatrics / Children’s Health
Pharma / Biotech Industry
Pharmacy / Pharmacists
Plastic Surgery
Pregnancy / Obstetrics
Premature Ejaculation
Preventive Medicine
Primary Care / General Practice
Prostate / Prostate Cancer
Psychology / Psychiatry
Public Health
Radiology / Nuclear Medicine
Regulatory Affairs / Drug Approvals
Rehabilitation / Physical Therapy
Respiratory
>
Categories S-Z
Schizophrenia
Seniors / Aging
Sexual Health / STDs
Sleep / Sleep Disorders
Smoking / Quit Smoking
Sports Medicine / Fitness
Statins
Stem Cell Research
Stroke
Swine Flu
Transplants / Organ Donations
Tropical Diseases
Tuberculosis
Urology / Nephrology
Vascular
Veterans / Ex-Servicemen
Veterinary
Viruses / Bacteria
Water - Air Quality / Agriculture
Women’s Health
View full category list
Unusual Tumors in the Ovary
Irene used to get red-faced at parties. But it wasn’t until her doctor made the connection between her irregular periods and her flushing that she learned she had carcinoid syndrome…
Talking with Your Doctor
Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors…
swine flu nutrition cancer cardiovascular diabetes hiv obesity pediatrics neurology dermatology urology pregnancy psychology medicare infectious diseases alcohol breast cancer women’s health asthma gastrointestinal alzheimer’s stem cell research prostate bones pain sexual health smoking eye health sleep sports medicine multiple sclerosis health insurance medical devices hypertension dentistry biology genetics depression it arthritis autism pharma industry fertility abortion liver disease mrsa seniors nursing anxiety allergy
Recommend reading articles:
Leave Your Reply Below